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Allogeneic Orthotopic Liver Transplantation in Mice: A Preliminary 
Study of Rejection Across Well-Defined MHC Barriers 
S. Oian, J.J. Fung, A.J. Demetris, and T.E. Starzl 
A mouse model of orthotopic liver transplantation (OLT) has recently been established in our center. 1 
In this study, OLT was performed between allogeneic 
mouse strains where the major and minor MHC antigenic 
barriers are well defined. Survival and the histopathologic 
patterns of rejection were correlated with the identity of 
MHC barrier. 
MATERIALS AND METHODS 
Ten to twelve· week-old male inbred mice were obtained from the 
Jackson Laboratory, Bar Harbor, Me. Orthotopic liver transplan-
tation was perfonned as described by Qian and coworkers. 1 
Briefly, following cholecystectomy and cuff preparations. the liver 
grafts were placed orthotopically after the native liver had been 
removed. The suprahepatk vena cava anastomosis was com-
pleted with a 10-0 running suture. The cuff technique was used for 
anastomosis of both the infrabepatic vena cava and portal vein. 
No attempt was made to reconstruct the graft arterial supply. The 
donor bile duct was connected to that ofthe recipient by inserting 
a polyethylene tube in both. Blood loss was replaced with 
Ringer's Lactate solution. No immunosuppressive therapy was 
used in this study. Animals !i\;ng less than I week postoperatively 
were considered as surgical deaths, and were excluded from 
analysis. An autopsy was perfonned on all animals sun.iving more 
than I week, and tissue from the liver graft was submitted for 
histologic analysis. In addition, wedged resection biopsies were 
perfonned in some long-term survivors to assess the structural 
integrity of the graft and to check for rejection. 
RESULTS 
lsografts 
All BALB/c liver isograft recipients survived for more than 
100 days (see Table). Microscopically, random sampling 
of several healthy isograft recipients showed mild portal 
tract expansion, because of mild ductular proliferation in a 
few animals. However. no cholestasis was noted. 
Allografts 
The survival of allograft recipients is shown in Table I. 
Liver grafts transplanted across both class I and II major 
and minor MHC barriers (C3H -+ C57 BUIO: BALB/c --+ 
C3H; and BtOBR --+ BtoD2) survived for only short 
periods (median. 15 to 16days; range, 8 to 41 days). On the 
other hand. liver aIklgraft recipients (ATH -+ ATL) of only 
class II disparate grafts and that of ASW -+ ATH and 
BlOD2 -+ BIOHTG combinations, transplanted across 
H-2D locus differences. survived longer than 100 days. 
Histopathologic studies showed that when class I and II 
major and minor histocompatibility barriers were 
breached, a brisk form of cellular rejection .... as found. It 
was characterized by a portal mononuclear inflammatory 
infiltrate with portal vein infiltration. and damage and 
extension into the lobules associated with infarcts. How-
ever. a more indolent form of liver rejection was seen 
when the H-2A and H-2E or H-2D loci were crossed. It 
was characterized by mild portal inflammation. which was 
often arranged in aggregates around bile ducts. Bile duct 
epithelial cell pyknosis and focal duct loss was seen in 
ATH -+ ATL combination. 
DISCUSSION 
This is the first attempt at defining the role of the MHC 
antigens in mouse liver allograft rejection: it has been 
previously done for skin and heart allografts.:!..J The results 
of this preliminary study showed that the se,'erity of liver 
graft rejection appeared to be related to the degree of 
disparity at the histocompatibility complex. A histologi-
cally similar form of acute cellular rejection \I.as seen when 
both class I or II in combination with minor histocompat· 
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TABLE 1. Survival of Uver Grafts 
Donor Recipin 0ispariIy 
BAlBIc BAl..S'c 
C3H C578lJl 0 K"AkE"O" + mH 
BAL8Ic C3H KdAdEdf)" + mH 
Bl0BR Bl0 D2 K" A kE"O" 
ATH ATL A"E-
ASW ATH 0-
81002 810HTG [)d 
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AcUI Survival 
lei) 
>100, >100, >100, >100, >100, 
8,15,41 
8, 13, 15. 15, 16 
9, 10. 16, 18,18 
38, >100, >100. >100, >100 
16, >100, >100. >100. >100 
14, >100, >100. >100 
Median SuMva 
lei) 
>100 
15 
15 
16 
>100 
>100 
>100 
705 
700 
ibility antigens were violated. Crossing class II loci or a 
single class I locus resulted in survival of longer than 100 
days. However. several of these long-term survivors have 
developed a pattern of rejection which is histologically 
similar to "chronic" rejection as seen in human liver 
allograft recipients. 4 Further studies are currently under-
way to more precisely define the role of the MHC antigens 
in liver allograft rejection and to determine whether an 
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acceptable animal model of chronic rejection can be de-
veloped. 
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